Christos C. Zouboulis

Prof. Dr. Christos C. Zouboulis

Dermatology, Venereology, Allergology, Immunology, Brandenburg Medical School Theodor Fontane, Neuruppin, Brandenburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2013 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
I(International Team for the Revision of the International Criteria for Behçet's Disease (ITR‐ICBD)
International Team for the Revision of the International Criteria for Behçet's Disease (ITR‐ICBD)
FDF. Davatchi
F. Davatchi
SAS. Assaad‐Khalil
S. Assaad‐Khalil
KCK.T. Calamia
K.T. Calamia
JCJ.E. Crook
J.E. Crook
NZN. Ziaei
N. Ziaei

30 January 2015 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis
NDN. Desai
N. Desai
LEL. Emtestam
L. Emtestam
RHR.E. Hunger
R.E. Hunger
DID. Ioannides
D. Ioannides
GJG.B.E. Jemec
G.B.E. Jemec

1 July 2012 in Dermato-Endocrinology
Verified
Journal Article
Open access
RGRuta Ganceviciene
Ruta Ganceviciene
ALAikaterini I. Liakou
Aikaterini I. Liakou
ATAthanasios Theodoridis
Athanasios Theodoridis
EMEvgenia Makrantonaki
Evgenia Makrantonaki
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis
Skin aging is a complex biological process influenced by a combination of endogenous or intrinsic and exogenous or extrinsic factors. Because of the fact that skin health and beauty is considered o...

11 September 2009 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
IKIchiro Kurokawa
Ichiro Kurokawa
FDF. William Danby
F. William Danby
QJQiang Ju
Qiang Ju
XWXiuli Wang
Xiuli Wang
LXLeihong Flora Xiang
Leihong Flora Xiang
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis
Abstract:  Interest in sebaceous gland physiology and its diseases is rapidly increasing. We provide a summarized update of the current knowledge of the pathobiology of acne vulgaris and new treatment concepts that have emerged in the last 3 years (2005–2008). We have tried to answer questions arising from the exploration of sebaceous gland biology, hormonal factors, hyperkeratinization, role of bacteria, sebum, nutrition, cytokines and toll‐like receptors (TLRs). Sebaceous glands play an important role as active participants in the innate immunity of the skin. They produce neuropeptides, excrete antimicrobial peptides and exhibit characteristics of stem cells. Androgens affect sebocytes and infundibular keratinocytes in a complex manner influencing cellular differentiation, proliferation, lipogenesis and comedogenesis. Retention hyperkeratosis in closed comedones and inflammatory papules is attributable to a disorder of terminal keratinocyte differentiation. Propionibacterium acnes, by acting on TLR‐2, may stimulate the secretion of cytokines, such as interleukin (IL)‐6 and IL‐8 by follicular keratinocytes and IL‐8 and ‐12 in macrophages, giving rise to inflammation. Certain P. acnes species may induce an immunological reaction by stimulating the production of sebocyte and keratinocyte antimicrobial peptides, which play an important role in the innate immunity of the follicle. Qualitative changes of sebum lipids induce alteration of keratinocyte differentiation and induce IL‐1 secretion, contributing to the development of follicular hyperkeratosis. High glycemic load food and milk may induce increased tissue levels of 5α‐dihydrotestosterone. These new aspects of acne pathogenesis lead to the considerations of possible customized therapeutic regimens. Current research is expected to lead to innovative treatments in the near future.

21 June 2017 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis
TTT Tzellos
T Tzellos
AKATHANASSIOS KYRGIDIS
ATHANASSIOS KYRGIDIS
GJG B E Jemec
G B E Jemec
FBF G Bechara
F G Bechara
EGEuropean Hidradenitis Suppurativa Foundation Investigator Group
European Hidradenitis Suppurativa Foundation Investigator Group
Background A validated tool for the dynamic severity assessment of hidradenitis suppurativa/acne inversa (HS) is lacking. Objectives To develop and validate a novel dynamic scoring system to assess the severity of HS. Methods A Delphi voting procedure was conducted among the members of the European Hidradenitis Suppurativa Foundation (EHSF) to achieve consensus towards an initial HS Severity Score System (HS4). Strengths and weaknesses of HS4 were examined by a multicentre prospective study. Multivariate logistic regression, discriminant analysis and receiver operating characteristic curves, as well as examination for correlation (Spearman's rho) and agreement (Cohen's kappa) with existing scores, were engaged to recognize the variables for a new International HS4 (IHS4) that was established by a second Delphi round. Results Consensus HS4 was based on number of skin lesions, number of skin areas involved and Dermatology Life Quality Index (DLQI), and was evaluated by a sample of 236 patients from 11 centres. Subsequently, a multivariate regression model calculated adjusted odds ratios for several clinical signs. Nodules, abscesses and draining tunnels resulted as the scoring variables. Three candidate scores were presented to the second Delphi round. The resulting IHS4 score is arrived at by the number of nodules (multiplied by 1) plus the number of abscesses (multiplied by 2) plus the number of draining tunnels (multiplied by 4). A total score of 3 or less signifies mild, 4–10 signifies moderate and 11 or higher signifies severe disease. Cohen's kappa was fair (κ = 0·32) compared with Hurley classification, and moderate (κ = 0·49) compared with Expert Opinion. Correlation was good (ρ > 0·6) with Hurley classification, Expert Opinion, Physician's Global Assessment and Modified Sartorius score, and moderate for DLQI (ρ = 0·36). Conclusions The novel IHS4 is a validated tool to dynamically assess HS severity and can be used both in real‐life and the clinical trials setting.

1 September 2004 in Clinics in Dermatology
Verified
Journal Article
Closed access
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis